Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

被引:75
作者
Bonazzi, Simone [1 ]
d'Hennezel, Eva [1 ]
Beckwith, Rohan E. J. [1 ]
Xu, Lei [1 ]
Fazal, Aleem [1 ]
Magracheva, Anna [1 ]
Ramesh, Radha [1 ]
Cernijenko, Artiom [1 ]
Antonakos, Brandon [1 ]
Bhang, Hyo-eun C. [1 ]
Caro, Roxana Garcia [1 ]
Cobb, Jennifer S. [1 ]
Ornelas, Elizabeth [2 ]
Ma, Xiaolei [2 ]
Wartchow, Charles A. [2 ]
Clifton, Matthew C. [1 ,2 ]
Forseth, Ry R. [3 ]
Fortnam, Bethany Hughes [1 ]
Lu, Hongbo [1 ]
Csibi, Alfredo [1 ]
Tullai, Jennifer [1 ]
Carbonneau, Seth [1 ]
Thomsen, Noel M. [1 ]
Larrow, Jay [1 ]
Chie-Leon, Barbara [2 ]
Hainzl, Dominik [1 ]
Gu, Yi [1 ]
Lu, Darlene [1 ]
Meyer, Matthew J. [1 ]
Alexander, Dylan [1 ]
Kinyamu-Akunda, Jacqueline [3 ]
Sabatos-Peyton, Catherine A. [1 ]
Dales, Natalie A. [1 ]
Zecri, Frederic J. [1 ]
Jain, Rishi K. [1 ]
Shulok, Janine [1 ]
Wang, Y. Karen [1 ]
Briner, Karin [1 ]
Porter, Jeffery A. [1 ]
Tallarico, John A. [1 ]
Engelman, Jeffrey A. [1 ]
Dranoff, Glenn [1 ]
Bradner, James E. [1 ]
Visser, Michael [1 ]
Solomon, Jonathan M. [1 ]
机构
[1] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[2] Novartis Inst Biomed Res, Emeryville, CA USA
[3] Novartis Inst Biomed Res, E Hanover, NJ USA
关键词
REGULATORY T-CELLS; BETA-GALACTOSIDASE COMPLEMENTATION; DEGRADATION; DYSFUNCTION; COMPLEX; TARGET;
D O I
10.1016/j.chembiol.2023.02.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Malignant tumors can evade destruction by the immune system by attracting immune-suppressive regulato-ry T cells (Treg) cells. The IKZF2 (Helios) transcription factor plays a crucial role in maintaining function and stability of Treg cells, and IKZF2 deficiency reduces tumor growth in mice. Here we report the discovery of NVP-DKY709, a selective molecular glue degrader of IKZF2 that spares IKZF1/3. We describe the recruit-ment-guided medicinal chemistry campaign leading to NVP-DKY709 that redirected the degradation selec-tivity of cereblon (CRBN) binders from IKZF1 toward IKZF2. Selectivity of NVP-DKY709 for IKZF2 was ratio-nalized by analyzing the DDB1:CRBN:NVP-DKY709:IKZF2(ZF2 or ZF2-3) ternary complex X-ray structures. Exposure to NVP-DKY709 reduced the suppressive activity of human Treg cells and rescued cytokine production in exhausted T-effector cells. In vivo, treatment with NVP-DKY709 delayed tumor growth in mice with a humanized immune system and enhanced immunization responses in cynomolgus monkeys. NVP-DKY709 is being investigated in the clinic as an immune-enhancing agent for cancer immunotherapy.
引用
收藏
页码:235 / +
页数:26
相关论文
共 60 条
[1]  
Arista L., 2021, BIFUNCTIONAL DEGRADE, P1
[2]   Helios Induces Epigenetic Silencing of Il2 Gene Expression in Regulatory T Cells [J].
Baine, Ian ;
Basu, Samik ;
Ames, Rachel ;
Sellers, Rani S. ;
Macian, Fernando .
JOURNAL OF IMMUNOLOGY, 2013, 190 (03) :1008-1016
[3]   Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency [J].
Boutboul, David ;
Kuehn, Hye Sun ;
de Wyngaert, Zoe Van ;
Niemela, Julie E. ;
Callebaut, Isabelle ;
Stoddard, Jennifer ;
Lenoir, Christelle ;
Barlogis, Vincent ;
Farnarier, Catherine ;
Vely, Frederic ;
Yoshida, Nao ;
Kojima, Seiji ;
Kanegane, Hirokazu ;
Hoshino, Akihiro ;
Hauck, Fabian ;
Lhermitte, Ludovic ;
Asnafi, Vahid ;
Roehrs, Philip ;
Chen, Shaoying ;
Verbsky, James W. ;
Calvo, Katherine R. ;
Husami, Ammar ;
Zhang, Kejian ;
Roberts, Joseph ;
Amrol, David ;
Sleaseman, John ;
Hsu, Amy P. ;
Holland, Steven M. ;
Marsh, Rebecca ;
Fischer, Alain ;
Fleisher, Thomas A. ;
Picard, Capucine ;
Latour, Sylvain ;
Rosenzweig, Sergio D. .
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07) :3071-3087
[4]   Helios Deficiency Has Minimal Impact on T Cell Development and Function [J].
Cai, Qi ;
Dierich, Andree ;
Oulad-Abdelghani, Mustapha ;
Chan, Susan ;
Kastner, Philippe .
JOURNAL OF IMMUNOLOGY, 2009, 183 (04) :2303-2311
[5]   Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality [J].
Chamberlain, Philip P. ;
D'Agostino, Laura A. ;
Ellis, J. Michael ;
Hansen, Joshua D. ;
Matyskiela, Mary E. ;
McDonald, Joseph J. ;
Riggs, Jennifer R. ;
Hamann, Lawrence G. .
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (12) :1592-1602
[6]   Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs [J].
Chamberlain, Philip P. ;
Lopez-Girona, Antonia ;
Miller, Karen ;
Carmel, Gilles ;
Pagarigan, Barbra ;
Chie-Leon, Barbara ;
Rychak, Emily ;
Corral, Laura G. ;
Ren, Yan J. ;
Wang, Maria ;
Riley, Mariko ;
Delker, Silvia L. ;
Ito, Takumi ;
Ando, Hideki ;
Mori, Tomoyuki ;
Hirano, Yoshinori ;
Handa, Hiroshi ;
Hakoshima, Toshio ;
Daniel, Thomas O. ;
Cathers, Brian E. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2014, 21 (09) :803-809
[7]   Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection [J].
Crawford, Alison ;
Angelosanto, Jill M. ;
Kao, Charlly ;
Doering, Travis A. ;
Odorizzi, Pamela M. ;
Barnett, Burton E. ;
Wherry, E. John .
IMMUNITY, 2014, 40 (02) :289-302
[8]   Drugging the 'undruggable' cancer targets [J].
Dang, Chi V. ;
Reddy, E. Premkumar ;
Shokat, Kevan M. ;
Soucek, Laura .
NATURE REVIEWS CANCER, 2017, 17 (08) :502-508
[9]   NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells [J].
Dixon, Andrew S. ;
Schwinn, Marie K. ;
Hall, Mary P. ;
Zimmerman, Kris ;
Otto, Paul ;
Lubben, Thomas H. ;
Butler, Braeden L. ;
Binkowski, Brock F. ;
Machleidt, Thomas ;
Kirkland, Thomas A. ;
Wood, Monika G. ;
Eggers, Christopher T. ;
Encell, Lance P. ;
Wood, Keith V. .
ACS CHEMICAL BIOLOGY, 2016, 11 (02) :400-408
[10]   Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome [J].
Donovan, Katherine A. ;
An, Jian ;
Nowak, Radoslaw P. ;
Yuan, Jingting C. ;
Fink, Emma C. ;
Berry, Bethany C. ;
Ebert, Benjamin L. ;
Fischer, Eric S. .
ELIFE, 2018, 7